Trial Profile
Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jun 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Jun 2014 New trial record